CINtec PLUS Cytology
Ventana Medical Systems, Inc. · Decision date Sep 4, 2025
What did the FDA decide?
FDA records P190024/S015 as a supplement to PMA P190024, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Sep 4, 2025.
FDA approval order statement
approval for the addition of two new suppliers for two different raw materials
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Pathology
- Decision date
- Sep 4, 2025
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
Regulatory record facts
- Identifier
- P190024/S015
- Regulatory pathway
- PMA supplement
- Applicant
- Ventana Medical Systems, Inc.
- Product code
- QKF
- Decision code
- OK30
- Decision date
- Sep 4, 2025
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Immunocytochemistry assay, p16/Ki-67.
- Applicant
- Ventana Medical Systems, Inc.
- Product code
- QKF
- FDA device class
- 3
Review the original FDA PMA listing for the original approval scope and linked supplements.
FDA decision timeline
P190024/S014 · Related supplement
CINtec PLUS Cytology
P190024/S015 received
Application receipt date recorded by FDA.
P190024/S015 · FDA decision
30-Day Notice
Timeline entries are records held by MedtechLedger for P190024. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P190024
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
CINtec PLUS CytologyP190024/S014 | Ventana Medical Systems, Inc. | PMA supplement | Jul 31, 2025 | FDA |
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Ventana Medical Systems, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 1910 E. Innovation Park Dr., Tucson, AZ, 85755
Sources and methodology
- Original FDA record: P190024/S015
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 21, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records